Simon Lovestone

Section of Old Age Psychiatry, Institute of Psychiatry, United Kingdom

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Psychiatry > Alzheimer's Disease (since 15 November 2005)

All recent recommendations

• 3.0
  Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
  Recommended by Simon Lovestone with Madhav Thambisetty
  
• 3.0
  Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.
  Recommended by Simon Lovestone
  
• 3.0
  Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.
  Recommended by Simon Lovestone
  
• 3.0
  Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.
  Recommended by Simon Lovestone
  
• 4.9
  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.
  Recommended by Massimo Pandolfo, Simon Lovestone, Rivka Inzelberg
  
• 3.0
  Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
  Recommended by Simon Lovestone